Children’s Mercy Kansas City, announced it is the first health care system to use 5-base HiFi sequencing, in the clinical setting to accelerate diagnoses for even more patients and families.

Azenta Life Sciences latest exciting products for biospecimen sample management will be on show at ISBER 2023 in Granada, Spain.

Range of highly selective anti-idiotypic antibodies now includes six antibodies specific to dupilumab and its biosimilars for bioanalysis and Drug Monitoring.

Extended long-term collaboration to provide significant additional bioconjugation capacity for commercialization of antibody-drug conjugates (ADCs) for use against hard-to-treat cancers.

Partnership between two Canadian life sciences leaders offers a commercial GMP manufacturing solution for Acuitas’ licensed partners developing promising next generation therapies.

Carcinotech and CELLINK plan to revolutionize the drug discovery market by leveraging CELLINK’s bioprinting solutions and Carcinotech’s expertise in producing 3D bioprinted living tumors to provide protocols for users to develop cutting-edge cancer models.

Newly-launched module set to accelerate drug discovery in therapeutic areas such as neuropsychiatry, epilepsy and neurodegeneration.

External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization.

Haier Biomedical is pleased to announce the launch of its new line of energy efficient TwinCool Frequency Conversion ULT Freezers for pharmaceutical, clinical research and public health laboratories.

The FlowLab Column™ from Uniqsis is an affordable flow chemistry system designed specifically for high temperature and pressure catalysis applications.